Fourteen patents were awarded to Utah inventors on Sept. 11, 2007. U.S. patents are granted each Tuesday. The new patents include:

• Wildland fire vehicle escape system. Georg B.L. Adams, Duchesne. Assigned to Lemur Group L.L.C., Salt Lake City. Filed May 3, 2006. Patent No. 7,267,114.

• Method and system for providing pharmaceutical product information to a patient. Robert Lammle, Salt Lake City. Filed June 23, 2003. Patent No. 7,267,278.

• Multi-function binding system. Matthew E. Miller, Provo; Shane R. Barney, Brady S. Fox, Douglas K. Furr, all of Orem. Assigned to Miller Sports International Inc., Provo. Filed June 15, 2005, claiming priority to multiple prior patent applications. Patent No. 7,267,357.

• Method for detecting forensic evidence. Calvin D. Ostler, Riverton; Densen Cao, Hongyan Li, both of Sandy; Zhaohui Lin, Salt Lake City. Assigned to CAO Group, Inc., West Jordan. Filed April 22, 2005, claiming priority to multiple prior patent applications. Patent No. 7,267,457.

• Light meter for detecting and measuring intensity of two or more wavelengths of light. Robert R. Scott, Riverton; Bruce S. McLean, Sandy. Assigned to Ultradent Products, Inc., South Jordan. Filed Aug. 9, 2004. Patent No. 7,267,546.

• System and apparatus for improving safety and thrust from a hydro-drive device. George I. Norman, Salt Lake City. Assigned to Enviroprop Corporation, Sarasota, Fla. Filed Jan. 17, 2006, claiming priority to multiple prior patent applications. Patent No. 7,267,589.

• Peptides from the E7 protein of human papilloma viruses 16 and 18 for detecting and/or diagnosing cervical and other human papilloma virus associated cancers. Mark J. Rosenfeld, Draper; Yao Xiong Hu, Mountain View, Calif. Assigned to Yao Xiong Hu, Mountain View, Calif. Filed Nov. 23, 2004, claiming priority to multiple prior patent applications. Patent No. 7,267,961.

• Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases. Alan L. Mueller, Scott T. Moe, both of Salt Lake City. Assigned to NPS Pharmaceuticals, Inc., Parsippany, N.J. Filed Feb. 13, 2006, claiming priority to multiple prior patent applications. Patent No. 7,268,166.